These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 16168470)

  • 21. Glycine receptors in the caudal pontine reticular formation: are they important for the inhibition of the acoustic startle response?
    Koch M; Friauf E
    Brain Res; 1995 Feb; 671(1):63-72. PubMed ID: 7728534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transient neuromotor phenotype in transgenic spastic mice expressing low levels of glycine receptor beta-subunit: an animal model of startle disease.
    Becker L; Hartenstein B; Schenkel J; Kuhse J; Betz H; Weiher H
    Eur J Neurosci; 2000 Jan; 12(1):27-32. PubMed ID: 10651857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The startle disease mutation Q266H, in the second transmembrane domain of the human glycine receptor, impairs channel gating.
    Moorhouse AJ; Jacques P; Barry PH; Schofield PR
    Mol Pharmacol; 1999 Feb; 55(2):386-95. PubMed ID: 9927632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of intracellular and extracellular domains mediating signal transduction in the inhibitory glycine receptor chloride channel.
    Lynch JW; Rajendra S; Pierce KD; Handford CA; Barry PH; Schofield PR
    EMBO J; 1997 Jan; 16(1):110-20. PubMed ID: 9009272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Startle disease mutations reduce the agonist sensitivity of the human inhibitory glycine receptor.
    Rajendra S; Lynch JW; Pierce KD; French CR; Barry PH; Schofield PR
    J Biol Chem; 1994 Jul; 269(29):18739-42. PubMed ID: 7518444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Propofol restores the function of "hyperekplexic" mutant glycine receptors in Xenopus oocytes and mice.
    O'Shea SM; Becker L; Weiher H; Betz H; Laube B
    J Neurosci; 2004 Mar; 24(9):2322-7. PubMed ID: 14999083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The startle disease mutation α1S270T predicts shortening of glycinergic synaptic currents.
    Wu Z; Lape R; Jopp-Saile L; O'Callaghan BJ; Greiner T; Sivilotti LG
    J Physiol; 2020 Aug; 598(16):3417-3438. PubMed ID: 32445491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Behavioral characterization of knockin mice with mutations M287L and Q266I in the glycine receptor α1 subunit.
    Blednov YA; Benavidez JM; Homanics GE; Harris RA
    J Pharmacol Exp Ther; 2012 Feb; 340(2):317-29. PubMed ID: 22037202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Compound heterozygosity and nonsense mutations in the alpha(1)-subunit of the inhibitory glycine receptor in hyperekplexia.
    Rees MI; Lewis TM; Vafa B; Ferrie C; Corry P; Muntoni F; Jungbluth H; Stephenson JB; Kerr M; Snell RG; Schofield PR; Owen MJ
    Hum Genet; 2001 Sep; 109(3):267-70. PubMed ID: 11702206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acoustic startle at baseline and during acute alcohol withdrawal in replicate mouse lines selectively bred for high or low alcohol preference.
    Chester JA; Barrenha GD
    Alcohol Clin Exp Res; 2007 Oct; 31(10):1633-44. PubMed ID: 17850641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A missense mutation in the gene encoding the alpha 1 subunit of the inhibitory glycine receptor in the spasmodic mouse.
    Ryan SG; Buckwalter MS; Lynch JW; Handford CA; Segura L; Shiang R; Wasmuth JJ; Camper SA; Schofield P; O'Connell P
    Nat Genet; 1994 Jun; 7(2):131-5. PubMed ID: 7920629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutation of an arginine residue in the human glycine receptor transforms beta-alanine and taurine from agonists into competitive antagonists.
    Rajendra S; Lynch JW; Pierce KD; French CR; Barry PH; Schofield PR
    Neuron; 1995 Jan; 14(1):169-75. PubMed ID: 7826634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GLRB is the third major gene of effect in hyperekplexia.
    Chung SK; Bode A; Cushion TD; Thomas RH; Hunt C; Wood SE; Pickrell WO; Drew CJ; Yamashita S; Shiang R; Leiz S; Longardt AC; Raile V; Weschke B; Puri RD; Verma IC; Harvey RJ; Ratnasinghe DD; Parker M; Rittey C; Masri A; Lingappa L; Howell OW; Vanbellinghen JF; Mullins JG; Lynch JW; Rees MI
    Hum Mol Genet; 2013 Mar; 22(5):927-40. PubMed ID: 23184146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of a mutation in the TM2-TM3 linker region of the glycine receptor alpha1 subunit on gating and allosteric modulation.
    Dupre ML; Broyles JM; Mihic SJ
    Brain Res; 2007 Jun; 1152():1-9. PubMed ID: 17434460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The frameshift mutation oscillator (Glra1(spd-ot)) produces a complete loss of glycine receptor alpha1-polypeptide in mouse central nervous system.
    Kling C; Koch M; Saul B; Becker CM
    Neuroscience; 1997 May; 78(2):411-7. PubMed ID: 9145798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel mutation of GLRA1 in Omani families with hyperekplexia and mild mental retardation.
    Al-Futaisi AM; Al-Kindi MN; Al-Mawali AM; Koul RL; Al-Adawi S; Al-Yahyaee SA
    Pediatr Neurol; 2012 Feb; 46(2):89-93. PubMed ID: 22264702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutations in the alpha 1 subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexia.
    Shiang R; Ryan SG; Zhu YZ; Hahn AF; O'Connell P; Wasmuth JJ
    Nat Genet; 1993 Dec; 5(4):351-8. PubMed ID: 8298642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel hyperekplexia-causing mutation in the pre-transmembrane segment 1 of the human glycine receptor alpha1 subunit reduces membrane expression and impairs gating by agonists.
    Castaldo P; Stefanoni P; Miceli F; Coppola G; Del Giudice EM; Bellini G; Pascotto A; Trudell JR; Harrison NL; Annunziato L; Taglialatela M
    J Biol Chem; 2004 Jun; 279(24):25598-604. PubMed ID: 15066993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acetylcholinesterase (AChE) gene modification in transgenic animals: functional consequences of selected exon and regulatory region deletion.
    Camp S; Zhang L; Marquez M; de la Torre B; Long JM; Bucht G; Taylor P
    Chem Biol Interact; 2005 Dec; 157-158():79-86. PubMed ID: 16289062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Familial hyperekplexia: startle disease. Clinical, electrophysiological and genetic study of a family].
    Bernasconi A; Regli F; Schorderet DF; Pescia G
    Rev Neurol (Paris); 1996; 152(6-7):447-50. PubMed ID: 8944241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.